The use of bowel in vaginal reconstruction Romano T. DeMarcoJohn C. Pope IVJohn W. Brock III Invited Commentary Pages: 409 - 411
Systematic review of anticholinergic agents: Clinical trials versus clinical effectiveness David R. Staskin Clinical Trials Report Pages: 419 - 420
Muscarinic receptors: What we know Harriette M. ScarperoRoger R. Dmochowski OriginalPaper Pages: 421 - 428
Overactive bladder and men: Indications for anticholinergics Ricardo R. GonzálezAlexis E. Te OriginalPaper Pages: 429 - 435
Trospium chloride: A quaternary amine with unique pharmacologic properties Raymond W. PakSteven P. PetrouDavid R. Staskin OriginalPaper Pages: 436 - 440
Nocturia: When is it not related to overactive bladder? Konstantin WalmsleyDavid R. Staskin OriginalPaper Pages: 441 - 445
Overactive bladder: Improving the efficacy of anticholinergics by dose escalation Scott A. MacDiarmid OriginalPaper Pages: 446 - 451
Tadalafil for the treatment of erectile dysfunction Culley C. Carson III Clinical Trials Report Pages: 455 - 456
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists Sharron H. FrancisJackie D. Corbin OriginalPaper Pages: 457 - 465
Tadalafil in the treatment of erectile dysfunction Anthony J. BellaGerald B. Brock OriginalPaper Pages: 472 - 478
Vardenafil: A new approach to the treatment of erectile dysfunction Wayne J. G. Hellstrom OriginalPaper Pages: 479 - 487
Sildenafil: A 4-year update in the treatment of 20 million erectile dysfunction patients Culley C. Carson III OriginalPaper Pages: 488 - 496